TD Asset Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

TD Asset Management’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-39,700	Closed	-$1.81M	–	1399
2017 Q4	$1.81M	Sell	39,700 -2,900	-7%	-$145K	﹤0.01%	909
2017 Q3	$1.91M	Buy	42,600 +10,600	+33%	+$361K	﹤0.01%	882
2017 Q2	$956K	Sell	32,000 -1,500	-4%	-$37K	﹤0.01%	1056
2017 Q1	$743K	Sell	33,500 -1,700	-5%	-$36.5K	﹤0.01%	1114
2016 Q4	$664K	Buy	+35,200	New	+$861K	﹤0.01%	1120

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

TD Asset Management's JUNO Position: Q1 2018 in Review

TD Asset Management sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 39,700 shares — an estimated $1.81M sold.

TD Asset Management first reported a position in JUNO in Q4 2016 and held it in 5 quarters. The position peaked at $1.91M in Q3 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

TD Asset Management reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
TD Asset Management sold 39,700 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $1.81M.
TD Asset Management first reported a position in Juno Therapeutics, Inc. in Q4 2016 and held it in 5 quarters.
TD Asset Management's Juno Therapeutics, Inc. position peaked at $1.91M in Q3 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on TD Asset Management's 13F filing for Q1 2018, filed 11 May 2018.